Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Molecular Cancer Therapeutics|March 11, 2011
Connexin-26 is a key factor mediating gemcitabine bystander effectLaura Garcia-Rodríguez, Sandra Pérez-Torras, Meritxell Carrió, et al.
Nature Protocols|January 12, 2013
Characterization of pluripotent stem cellsMercè Martí, Lola Mulero, Cristina Pardo, et al.
STAR Protocols|March 28, 2023
Generation of human iPSC-derived neurofibromaspheres for in vitro and in vivo usesHelena Mazuelas, Itziar Uriarte-Arrazola, Juana Fernández-Rodríguez, et al.
JCI Insight|January 4, 2024
Unbalancing cAMP and Ras/MAPK pathways as a therapeutic strategy for cutaneous neurofibromasHelena Mazuelas, Miriam Magallón-Lorenz, Itziar Uriarte-Arrazola, et al.
Cancer Cell International|July 18, 2025
New models for MPNST: establishment and comprehensive characterization of two tumor cell linesSara Ortega-Bertran, Edgar Creus-Bachiller, Miriam Magallón-Lorenz, et al.
Stem Cell Reports|February 5, 2019
Reprogramming Captures the Genetic and Tumorigenic Properties of Neurofibromatosis Type 1 Plexiform NeurofibromasMeritxell Carrió, Helena Mazuelas, Yvonne Richaud-Patin, et al.
Human Genetics|June 1, 2021
Chromosomal translocations inactivating CDKN2A support a single path for malignant peripheral nerve sheath tumor initiationMiriam Magallón-Lorenz, Juana Fernández-Rodríguez, Ernest Terribas, et al.
Pageof 3